Digital Health Acquisition Corp

Digital Health Acquisition Corp

VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts suggest buying Digital Health Acquisition Corp's stock due to its positive outlook.

Average

Financial Health

Digital Health Acquisition Corp is generating moderate revenue and cash flow, with a reasonable profit margin.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring VSEE

Employee Mental Health As A Benefit

Employee Mental Health As A Benefit

Discover companies transforming workplace wellness through innovative mental health solutions. These carefully selected stocks represent businesses helping corporations attract and retain talent by offering digital therapy, virtual counseling, and wellness technologies as employee benefits.

Published: June 17, 2025

Explore Basket
Digital Therapeutics

Digital Therapeutics

Software that works like medicine. These companies are creating clinically validated digital tools that treat and manage diseases just like traditional pharmaceuticals, but with the scalability of technology. Professional investors see enormous potential in this rapidly evolving healthcare frontier.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

πŸ“ˆ

Potential Deal Catalyst

A completed merger could change the company’s profile quickly and create growth opportunities, though outcomes depend on the target and terms and performance can vary.

🌍

Digital Health Theme

The broader sector benefits from telemedicine and data analytics tailwinds, but regulatory hurdles and adoption timelines mean returns are uncertain.

⚑

Small-cap Volatility

With a modest market cap, shares can be thinly traded and move sharply; suitable for investors who accept higher risk and can tolerate short-term swings.

Why invest with Nemo?

Nemo Logo Fade
πŸ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

πŸ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

πŸ’°

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions